Traphaco JSC (HOSE:TRA)
68,500
-2,400 (-3.39%)
At close: Mar 9, 2026
Traphaco JSC Revenue
In the year 2025, Traphaco JSC had annual revenue of 2.65T VND with 12.98% growth. Traphaco JSC had revenue of 716.00B in the quarter ending December 31, 2025, with 16.26% growth.
Revenue
2,651.81B
Revenue Growth
+12.98%
P/S Ratio
1.07
Revenue / Employee
1.59B
Employees
1,670
Market Cap
2,839.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2,651.81B | 304.59B | 12.98% |
| Dec 31, 2024 | 2,347.22B | 47.99B | 2.09% |
| Dec 31, 2023 | 2,299.24B | -99.68B | -4.16% |
| Dec 31, 2022 | 2,398.92B | 238.08B | 11.02% |
| Dec 31, 2021 | 2,160.84B | 251.97B | 13.20% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cuu Long Pharmaceutical JSC | 1,321.59B |
| Domesco Medical Import - Export Joint-Stock | 2,078.82B |
| Binh Dinh Pharmaceutical and Medical Equipment JSC | 1,865.23B |
| OPC Pharmaceutical JSC | 1,122.99B |
| Ha Tay Pharmaceutical JSC | 2,402.04B |
| Central Pharmaceutical Joint Stock Company No3 | 438.01B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.57B |
| Vidipha Central Pharmaceutical JSC | 950.89B |